Austin Roxanne S's Form 4/A amendment
AmendedAbbVie Inc. (ABBV) · filed May 9, 2023
- Accession no.
- 0001415889-23-007667
- Filed
- May 9, 2023
- Trade date
- Feb 17, 2023
- Filing delay
- 81 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Feb 21, 2023
This filing lists 1 non-derivative transaction. Open-market sales total $936.4K. It was filed 81 days after the trade.
This amendment replaces 0001415889-23-002947 (filed Feb 21, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Austin Roxanne SCIK 0001061632 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2023 | Common Stock, $0.01 par value | SSaleDisposed | −6,222 | $150.50 | −$936,411 | 34,483 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
This amendment has no footnotes.
Remarks
This amendment includes the sale of 6,222 additional shares which, due to an administrative error, were inadvertently omitted from the previously-filed form.